Paragon Genomics

Paragon Genomics is a company that develops and commercializes ultra-high multiplex polymerase chain reaction-based target enrichment solutions for next-generation sequencing (NGS). Its proprietary CleanPlex background-removing technology enables NGS customers to develop targeted sequencing assays. The company serves a range of sectors, including cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.